ARCHIVES

Herceptin Recommended As Adjuvant For HER2 Positive Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 5 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

Ohio State Wins P01 Grant

December 6, 2002

FDA, NCI, Congress Shape Pediatric Drug Development Proposals

April 11, 2003

Centers Recruting Patients With Mantle Cell Lymphoma

October 29, 2004

Schering to Pay $435M to Settle Federal Charges.

January 26, 2007

Two Studies Suggest Positive HPV Status Can Indicate Improved Patient Outcomes

February 28, 2014

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

May 8, 2013